BioXcel Therapeutics Shares Rise After Preliminary Q2 Revenue Exceeds Estimates
BioXcel Therapeutics Shares Rise After Preliminary Q2 Revenue Exceeds Estimates
Bioxcel Therapeutics公司在Q2财报公布前的营业收入已超过预期,股价上涨。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册